Generated: December 16, 2017
DrugPatentWatch Database Preview
« Back to Dashboard
When do Doxycycline patents expire, and when can generic versions of Doxycycline launch?
Doxycycline is a drug marketed by Alembic Pharms Ltd, G And W Labs Inc, Impax Labs Inc, Lupin Ltd, Mayne Pharma Inc, Mylan Pharms Inc, Par Pharm, Sandoz Inc, Sun Pharm Inds Ltd, Watson Labs, Zydus Pharms Usa Inc, Chartwell Life Sci, Mylan Labs Ltd, West-ward Pharms Int, Heritage Pharms Inc, Lannett, Mylan, Sun Pharm Industries, Pliva, Medicis, Actavis Labs Fl Inc, Amneal Pharms, Halsey, Heather, Hikma Intl Pharms, Interpharm, Mutual Pharm, Pvt Form, Ranbaxy, Superpharm, Warner Chilcott, Actavis Elizabeth, Prinston Inc, Amneal Pharms Co, Caribe Holdings, Epic Pharma Llc, Ivax Sub Teva Pharms, Larken Labs, Novel Labs Inc, and Vintage Pharms. and is included in seventy-eight NDAs.
The generic ingredient in DOXYCYCLINE is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety-four suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the doxycycline hyclate profile page.
US Patents and Regulatory Information
|Chartwell Life Sci||DOXYCYCLINE HYCLATE||doxycycline hyclate||CAPSULE;ORAL||062500-001||Sep 11, 1984||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||DOXYCYCLINE HYCLATE||doxycycline hyclate||CAPSULE;ORAL||061717-002||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Lannett||DOXYCYCLINE||doxycycline||TABLET;ORAL||065285-001||Dec 8, 2005||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|West-ward Pharms Int||DOXYCYCLINE||doxycycline hyclate||INJECTABLE;INJECTION||062569-001||Mar 9, 1988||AP||RX||No||Yes||► Subscribe||► Subscribe||► Subscribe|
|Mylan||DOXYCYCLINE HYCLATE||doxycycline hyclate||CAPSULE;ORAL||062337-001||Mar 29, 1982||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Mylan||DOXYCYCLINE HYCLATE||doxycycline hyclate||TABLET, DELAYED RELEASE;ORAL||090431-004||Apr 29, 2016||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Sun Pharm Industries||DOXYCYCLINE HYCLATE||doxycycline hyclate||TABLET;ORAL||062677-001||Jul 10, 1986||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Par Pharm||DOXYCYCLINE||doxycycline||TABLET;ORAL||065070-001||Dec 15, 2000||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Impax Labs Inc||DOXYCYCLINE HYCLATE||doxycycline hyclate||TABLET, DELAYED RELEASE;ORAL||090505-002||Dec 28, 2010||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Sun Pharm Industries||DOXYCYCLINE||doxycycline||TABLET;ORAL||065471-002||Apr 17, 2009||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
« Back to Dashboard
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.